30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Scholar Rock Holding Corp (SRRK)

Track

Over the last 90 days, Scholar Rock Holding Corp. has seen significant insider selling, with a net value of -$3.15 million. Executives have been the primary sellers, with no insider purchases recorded. This activity occurred despite a relatively stable stock performance over the same period, with a 1.4% increase in the last 90 days.
Stock chart
Ticker: SRRK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Woods Keith
Chief Operating Officer
1 sale — total 506,651 USD
Sale 16 Apr 2026
Value US$3,913,160.34 | Price 56.57 | Shares 319
Sale 16 Apr 2026
Value US$2,367,931.60 | Price 408.62 | Shares 70,289
Sale 16 Apr 2026
Value US$516,070.54 | Price 49.57 | Shares 10,410
Sale 16 Apr 2026
Value US$1,517,723.32 | Price 49.57 | Shares 30,615
Proposed sale 6 Apr 2026
Value US$1,170,634.00 | Price 50.01 | Shares 23,408
Planned sale 23 Feb 2026
Value US$9,696.00 | Price 48.48 | Shares 200
Planned sale 23 Feb 2026
Value US$41,014.99 | Price 47.86 | Shares 857
Planned sale 23 Feb 2026
Value US$348,639.72 | Price 46.94 | Shares 7,427
Proposed sale 23 Feb 2026
Value US$409,947.00 | Price 48.32 | Shares 8,484
Sale 17 Feb 2026
Value US$193,417.73 | Price 46.53 | Shares 4,157
Sale 17 Feb 2026
Value US$445,740.16 | Price 46.53 | Shares 9,580
Sale 17 Feb 2026
Value US$420,382.29 | Price 46.53 | Shares 9,035
Sale 17 Feb 2026
Value US$371,713.79 | Price 46.53 | Shares 7,989
Planned sale 22 Jan 2026
Value US$598,748.54 | Price 46.85 | Shares 12,779
Planned sale 22 Jan 2026
Value US$97,188.99 | Price 45.87 | Shares 2,119
Proposed sale 22 Jan 2026
Value US$686,053.00 | Price 46.05 | Shares 14,898
Sale 16 Jan 2026
Value US$257,881.70 | Price 44.48 | Shares 5,798
Sale 16 Jan 2026
Value US$356,533.24 | Price 44.48 | Shares 8,016
Sale 16 Jan 2026
Value US$373,879.55 | Price 44.48 | Shares 8,406
Sale 16 Jan 2026
Value US$293,552.82 | Price 44.48 | Shares 6,600
Planned sale 14 Jan 2026
Value US$592,611.26 | Price 45.20 | Shares 13,112
Sale 13 Jan 2026
Value US$715,438.50 | Price 42.70 | Shares 16,755
Sale 13 Jan 2026
Value US$2,453,115.00 | Price 42.70 | Shares 57,450
Sale 13 Jan 2026
Value US$715,054.20 | Price 42.70 | Shares 16,746
Sale 13 Jan 2026
Value US$872,702.60 | Price 42.70 | Shares 20,438
Sale 16 Dec 2025
Value US$12,497.63 | Price 44.63 | Shares 280
Sale 16 Dec 2025
Value US$31,854.05 | Price 43.88 | Shares 726
Proposed sale 16 Dec 2025
Value US$45,511.00 | Price 45.24 | Shares 1,006
Planned sale 4 Dec 2025
Value US$6,169,788.18 | Price 45.21 | Shares 136,462
Proposed sale 4 Dec 2025
Value US$6,433,178.00 | Price 43.01 | Shares 149,574
Buy 7 Oct 2025
Value US$180,390.91 | Price 40.97 | Shares 4,403
Buy 7 Oct 2025
Value US$498,232.00 | Price 40.18 | Shares 12,400
Buy 7 Oct 2025
Value US$503,010.76 | Price 39.31 | Shares 12,796
Buy 6 Oct 2025
Value US$543,320.96 | Price 39.52 | Shares 13,748
Buy 6 Oct 2025
Value US$3,127,780.84 | Price 38.68 | Shares 80,863
Buy 6 Oct 2025
Value US$697,706.46 | Price 37.89 | Shares 18,414
Buy 3 Oct 2025
Value US$11,963,174.00 | Price 37.42 | Shares 319,700
Buy 3 Oct 2025
Value US$2,083,268.22 | Price 36.74 | Shares 56,703
Buy 3 Oct 2025
Value US$392,101.71 | Price 35.61 | Shares 11,011
Planned sale 22 Sep 2025
Value US$102,846.23 | Price 30.67 | Shares 3,353
Proposed sale 22 Sep 2025
Value US$102,846.00 | Price 30.67 | Shares 3,353
Planned sale 16 Sep 2025
Value US$2,522.92 | Price 33.20 | Shares 76
Planned sale 16 Sep 2025
Value US$30,202.77 | Price 32.48 | Shares 930
Sale 16 Sep 2025
Value US$106,526.56 | Price 33.52 | Shares 3,178
Proposed sale 16 Sep 2025
Value US$32,726.00 | Price 32.53 | Shares 1,006
Sale 18 Aug 2025
Value US$67,880.20 | Price 31.17 | Shares 2,178
Planned sale 16 Jul 2025
Value US$445,688.33 | Price 40.02 | Shares 11,136
Planned sale 8 Jul 2025
Value US$828,898.02 | Price 34.44 | Shares 24,066
Proposed sale 8 Jul 2025
Value US$853,862.00 | Price 35.48 | Shares 24,066
Planned sale 23 Jun 2025
Value US$369,817.65 | Price 33.21 | Shares 11,136
Planned sale 23 Jun 2025
Value US$90,547.22 | Price 32.74 | Shares 2,766
Planned sale 23 Jun 2025
Value US$564,357.10 | Price 32.16 | Shares 17,550
Sale 16 Jun 2025
Value US$197,960.66 | Price 32.00 | Shares 6,186
Sale 16 Jun 2025
Value US$117,381.14 | Price 32.00 | Shares 3,668
Planned sale 16 Jun 2025
Value US$1,756.56 | Price 32.53 | Shares 54
Planned sale 16 Jun 2025
Value US$95,131.82 | Price 31.96 | Shares 2,977
Sale 16 Jun 2025
Value US$238,154.42 | Price 32.00 | Shares 7,442
Proposed sale 5 Jun 2025
Value US$636,967.00 | Price 32.50 | Shares 19,599
Planned sale 29 May 2025
Value US$131,268.72 | Price 29.83 | Shares 4,400
Planned sale 29 May 2025
Value US$29,241.90 | Price 29.24 | Shares 1,000
Planned sale 29 May 2025
Value US$15,021.75 | Price 30.04 | Shares 500
Planned sale 29 May 2025
Value US$145,440.82 | Price 29.68 | Shares 4,900
Planned sale 29 May 2025
Value US$148,429.12 | Price 29.84 | Shares 4,975
Planned sale 29 May 2025
Value US$32,154.98 | Price 29.23 | Shares 1,100
Planned sale 29 May 2025
Value US$48,611.66 | Price 30.01 | Shares 1,620
Planned sale 29 May 2025
Value US$152,000.36 | Price 29.63 | Shares 5,130
Planned sale 29 May 2025
Value US$81,895.70 | Price 29.83 | Shares 2,745
Planned sale 29 May 2025
Value US$18,408.35 | Price 29.22 | Shares 630
Planned sale 29 May 2025
Value US$42,004.34 | Price 30.00 | Shares 1,400
Planned sale 29 May 2025
Value US$138,526.33 | Price 29.63 | Shares 4,675
Proposed sale 29 May 2025
Value US$200,205.00 | Price 29.66 | Shares 6,750
Proposed sale 29 May 2025
Value US$160,164.00 | Price 29.66 | Shares 5,400
Proposed sale 29 May 2025
Value US$100,103.00 | Price 29.66 | Shares 3,375
Proposed sale 29 May 2025
Value US$1,443,345.00 | Price 29.66 | Shares 48,663
Proposed sale 29 May 2025
Value US$160,164.00 | Price 29.66 | Shares 5,400
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-16 S Sale
1.1
Woods Keith

Chief Operating Officer

Officer
319 +18.1%
56.57
US$3,913,160 		319 +18.1% 56.57 US$3,913,160
2026-04-20 2026-04-16 S Sale
2.4
Vaishnaw Akshay

President of R&D

Executive Director
70,289 -8.4%
408.62
US$2,367,932 		70,289 -8.4% 408.62 US$2,367,932
2026-04-20 2026-04-16 S Sale
2.7
Sinha Vikas

Chief Financial Officer

Officer
57,266 -10.7%
123.08
US$1,489,535 		57,266 -10.7% 123.08 US$1,489,535
2026-04-20 2026-04-16 S Sale
3.0
Hallal David

Chief Executive Officer

Executive Director
30,615 -1.8%
49.57
US$1,517,723 		30,615 -1.8% 49.57 US$1,517,723
2026-04-06 2026-04-06 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
23,408
50.01
US$1,170,634 		23,408 50.01 US$1,170,634
2026-02-25 2026-02-23 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
200 -0.2%
48.48
US$9,696 		200 -0.2% 48.48 US$9,696
2026-02-25 2026-02-23 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
857 -0.9%
47.86
US$41,015 		857 -0.9% 47.86 US$41,015
2026-02-25 2026-02-23 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
7,427 -6.9%
46.94
US$348,640 		7,427 -6.9% 46.94 US$348,640
2026-02-23 2026-02-23 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
8,484
48.32
US$409,947 		8,484 48.32 US$409,947
2026-02-19 2026-02-17 S Sale
2.9
Marantz Jing L.

CHIEF MEDICAL OFFICER

Officer
4,157 -3.2%
46.53
US$193,418 		4,157 -3.2% 46.53 US$193,418
2026-02-19 2026-02-17 S Sale
3.3
Ho Junlin

GENERAL COUNSEL

Officer
9,580 -3.8%
46.53
US$445,740 		9,580 -3.8% 46.53 US$445,740
2026-02-19 2026-02-17 S Sale
3.2
Parlavecchio Caryn

CHRO

Officer
9,035 -5.1%
46.53
US$420,382 		9,035 -5.1% 46.53 US$420,382
2026-02-19 2026-02-17 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
7,989 -7.0%
46.53
US$371,714 		7,989 -7.0% 46.53 US$371,714
2026-01-23 2026-01-22 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
12,779 -13.0%
46.85
US$598,749 		12,779 -13.0% 46.85 US$598,749
2026-01-23 2026-01-22 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
2,119 -2.1%
45.87
US$97,189 		2,119 -2.1% 45.87 US$97,189
2026-01-22 2026-01-22 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
14,898
46.05
US$686,053 		14,898 46.05 US$686,053
2026-01-21 2026-01-16 S Sale
2.9
Marantz Jing L.

CHIEF MEDICAL OFFICER

Officer
5,798 -5.7%
44.48
US$257,882 		5,798 -5.7% 44.48 US$257,882
2026-01-21 2026-01-16 S Sale
3.3
Ho Junlin

GENERAL COUNSEL

Officer
8,016 -3.6%
44.48
US$356,533 		8,016 -3.6% 44.48 US$356,533
2026-01-21 2026-01-16 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
8,406 -7.7%
44.48
US$373,880 		8,406 -7.7% 44.48 US$373,880
2026-01-21 2026-01-16 S Sale
3.2
Parlavecchio Caryn

CHRO

Officer
6,600 -4.2%
44.48
US$293,553 		6,600 -4.2% 44.48 US$293,553
2026-01-16 2026-01-14 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
13,112 -10.7%
45.20
US$592,611 		13,112 -10.7% 45.20 US$592,611
2026-01-15 2026-01-13 S Sale
2.7
Sinha Vikas

Chief Financial Officer

Officer
16,755 -2.8%
42.70
US$715,438 		16,755 -2.8% 42.70 US$715,438
2026-01-15 2026-01-13 S Sale
3.0
Hallal David

Chief Executive Officer

Executive Director
57,450 -3.6%
42.70
US$2,453,115 		57,450 -3.6% 42.70 US$2,453,115
2026-01-15 2026-01-13 S Sale
1.1
Woods Keith

Chief Operating Officer

Officer
16,746 -2.8%
42.70
US$715,054 		16,746 -2.8% 42.70 US$715,054
2026-01-15 2026-01-13 S Sale
2.4
Vaishnaw Akshay

President of R&D

Executive Director
20,438 -3.3%
42.70
US$872,703 		20,438 -3.3% 42.70 US$872,703
2025-12-18 2025-12-16 S Sale
1.5
Peng Katie
Non-Executive Director
280 -0.8%
44.63
US$12,498 		280 -0.8% 44.63 US$12,498
2025-12-18 2025-12-16 S Sale
1.5
Peng Katie
Non-Executive Director
726 -2.1%
43.88
US$31,854 		726 -2.1% 43.88 US$31,854
2025-12-16 2025-12-16 PrS Proposed sale
1.5
Katie Peng

Director

Non-Executive Director
1,006
45.24
US$45,511 		1,006 45.24 US$45,511
2025-12-05 2025-12-04 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
136,462 -55.6%
45.21
US$6,169,788 		136,462 -55.6% 45.21 US$6,169,788
2025-12-04 2025-12-04 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
149,574
43.01
US$6,433,178 		149,574 43.01 US$6,433,178
2025-12-16 2025-10-07 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
4,403 +0.8%
40.97
US$180,391 		4,403 +0.8% 40.97 US$180,391
2025-12-16 2025-10-07 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
12,400 +2.4%
40.18
US$498,232 		12,400 +2.4% 40.18 US$498,232
2025-12-16 2025-10-07 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
12,796 +2.6%
39.31
US$503,011 		12,796 +2.6% 39.31 US$503,011
2025-10-07 2025-10-06 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
13,748 +2.8%
39.52
US$543,321 		13,748 +2.8% 39.52 US$543,321
2025-10-07 2025-10-06 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
80,863 +19.9%
38.68
US$3,127,781 		80,863 +19.9% 38.68 US$3,127,781
2025-10-07 2025-10-06 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
18,414 +4.8%
37.89
US$697,706 		18,414 +4.8% 37.89 US$697,706
2025-10-07 2025-10-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
319,700 +472.1%
37.42
US$11,963,174 		319,700 +472.1% 37.42 US$11,963,174
2025-10-07 2025-10-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
56,703 +515.0%
36.74
US$2,083,268 		56,703 +515.0% 36.74 US$2,083,268
2025-10-07 2025-10-03 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
11,011 +inf%
35.61
US$392,102 		11,011 +inf% 35.61 US$392,102
2025-09-24 2025-09-22 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
3,353 -3.0%
30.67
US$102,846 		3,353 -3.0% 30.67 US$102,846
2025-09-22 2025-09-22 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
3,353
30.67
US$102,846 		3,353 30.67 US$102,846
2025-09-17 2025-09-16 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
76 -0.2%
33.20
US$2,523 		76 -0.2% 33.20 US$2,523
2025-09-17 2025-09-16 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
930 -2.7%
32.48
US$30,203 		930 -2.7% 32.48 US$30,203
2025-09-17 2025-09-16 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
3,178 -2.8%
33.52
US$106,527 		3,178 -2.8% 33.52 US$106,527
2025-09-16 2025-09-16 PrS Proposed sale
1.5
Katie Peng

Director

Non-Executive Director
1,006
32.53
US$32,726 		1,006 32.53 US$32,726
2025-08-19 2025-08-18 S Sale
3.2
Parlavecchio Caryn

CHRO

Officer
2,178 -1.4%
31.17
US$67,880 		2,178 -1.4% 31.17 US$67,880
2025-07-18 2025-07-16 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
11,136 -100.0%
40.02
US$445,688 		11,136 -100.0% 40.02 US$445,688
2025-07-10 2025-07-08 PlS Planned sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
24,066 -17.2%
34.44
US$828,898 		24,066 -17.2% 34.44 US$828,898
2025-07-08 2025-07-08 PrS Proposed sale
3.4
Mohammed Qatanani

Officer

Officer
24,066
35.48
US$853,862 		24,066 35.48 US$853,862
2025-06-25 2025-06-23 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
11,136 -50.0%
33.21
US$369,818 		11,136 -50.0% 33.21 US$369,818
2025-06-25 2025-06-23 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
2,766 -10.3%
32.74
US$90,547 		2,766 -10.3% 32.74 US$90,547
2025-06-25 2025-06-23 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
17,550 -39.5%
32.16
US$564,357 		17,550 -39.5% 32.16 US$564,357
2025-06-17 2025-06-16 S Sale
3.2
Parlavecchio Caryn

CHRO

Officer
6,186 -3.8%
32.00
US$197,961 		6,186 -3.8% 32.00 US$197,961
2025-06-17 2025-06-16 S Sale
3.4
Qatanani Mo

CHIEF SCIENTIFIC OFFICER

Officer
3,668 -2.6%
32.00
US$117,381 		3,668 -2.6% 32.00 US$117,381
2025-06-17 2025-06-16 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
54 -0.2%
32.53
US$1,757 		54 -0.2% 32.53 US$1,757
2025-06-17 2025-06-16 PlS Planned sale
1.5
Peng Katie
Non-Executive Director
2,977 -7.8%
31.96
US$95,132 		2,977 -7.8% 31.96 US$95,132
2025-06-17 2025-06-16 S Sale
3.3
Ho Junlin

GENERAL COUNSEL

Officer
7,442 -3.2%
32.00
US$238,154 		7,442 -3.2% 32.00 US$238,154
2025-06-05 2025-06-05 PrS Proposed sale
3.9
Edward Myles

Former Officer

Officer
19,599
32.50
US$636,967 		19,599 32.50 US$636,967
2025-05-30 2025-05-29 PlS Planned sale
3.2
Burow Kristina
Non-Executive Director
4,400 -17.3%
29.83
US$131,269 		4,400 -17.3% 29.83 US$131,269
2025-05-30 2025-05-29 PlS Planned sale
3.2
Burow Kristina
Non-Executive Director
1,000 -3.8%
29.24
US$29,242 		1,000 -3.8% 29.24 US$29,242
2025-05-30 2025-05-29 PlS Planned sale
Reed Joshua
Non-Executive Director
500 -3.1%
30.04
US$15,022 		500 -3.1% 30.04 US$15,022
2025-05-30 2025-05-29 PlS Planned sale
Reed Joshua
Non-Executive Director
4,900 -23.2%
29.68
US$145,441 		4,900 -23.2% 29.68 US$145,441
2025-05-30 2025-05-29 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
4,975 -17.1%
29.84
US$148,429 		4,975 -17.1% 29.84 US$148,429
2025-05-30 2025-05-29 PlS Planned sale
FLIER JEFFREY S.
Non-Executive Director
1,100 -3.6%
29.23
US$32,155 		1,100 -3.6% 29.23 US$32,155
2025-05-30 2025-05-29 PlS Planned sale
2.4
Vaishnaw Akshay

President of R&D

Executive Director
1,620 -0.3%
30.01
US$48,612 		1,620 -0.3% 30.01 US$48,612
2025-05-30 2025-05-29 PlS Planned sale
2.4
Vaishnaw Akshay

President of R&D

Executive Director
5,130 -0.8%
29.63
US$152,000 		5,130 -0.8% 29.63 US$152,000
2025-05-30 2025-05-29 PlS Planned sale
Gilman Michael
Non-Executive Director
2,745 -4.7%
29.83
US$81,896 		2,745 -4.7% 29.83 US$81,896
2025-05-30 2025-05-29 PlS Planned sale
Gilman Michael
Non-Executive Director
630 -1.1%
29.22
US$18,408 		630 -1.1% 29.22 US$18,408
2025-05-30 2025-05-29 PlS Planned sale
3.4
Brudnick Richard
Non-Executive Director
1,400 -8.5%
30.00
US$42,004 		1,400 -8.5% 30.00 US$42,004
2025-05-30 2025-05-29 PlS Planned sale
3.4
Brudnick Richard
Non-Executive Director
4,675 -22.1%
29.63
US$138,526 		4,675 -22.1% 29.63 US$138,526
2025-05-29 2025-05-29 PrS Proposed sale
2.4
Akshay Vaishnaw

Director

Non-Executive Director
6,750
29.66
US$200,205 		6,750 29.66 US$200,205
2025-05-29 2025-05-29 PrS Proposed sale
Joshua Reed

Director

Non-Executive Director
5,400
29.66
US$160,164 		5,400 29.66 US$160,164
2025-05-29 2025-05-29 PrS Proposed sale
Michael Gilman

Director

Non-Executive Director
3,375
29.66
US$100,103 		3,375 29.66 US$100,103
2025-05-29 2025-05-29 PrS Proposed sale
Jeffrey S. Flier

Director

Non-Executive Director
48,663
29.66
US$1,443,345 		48,663 29.66 US$1,443,345
2025-05-29 2025-05-29 PrS Proposed sale
3.2
Kristina Burow

Director

Non-Executive Director
5,400
29.66
US$160,164 		5,400 29.66 US$160,164
Explore more

More insider trading research around Scholar Rock Holding Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America